{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:27:51Z","timestamp":1793042871977,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jri.2023.104157","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T16:25:20Z","timestamp":1696091120000},"page":"104157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"160","author":[{"given":"Marcelo Borges","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Muniz","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Alves","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Ferreira","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda Maia","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Machado Luz","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Cruz","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Yzadora Moura","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Oliveira","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Barini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2023.104157_bib1","doi-asserted-by":"crossref","first-page":"19039","DOI":"10.1002\/jcp.28543","article-title":"Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1\/Th2 ratio","volume":"234","author":"Azizi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.jri.2023.104157_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/a-1056-3148","article-title":"Tacrolimus improves the implantation rate in patients with elevated Th1\/2 helper cell ratio and repeated implantation failure (RIF)","volume":"80","author":"Bahrami-Asl","year":"2020","journal-title":"Geburtshilfe Frau"},{"key":"10.1016\/j.jri.2023.104157_bib3","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"Bender Atik","year":"2023","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.jri.2023.104157_bib4","article-title":"The use of immunotherapies for recurrent miscarriage: an overview of systematic reviews and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib5","article-title":"Peripheral blood natural killer cell cytotoxicity in recurrent miscarriage: a systematic review and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13408","article-title":"Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure","volume":"85","author":"Cavalcante","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13525","article-title":"Improved pregnancy outcomes of cyclosporine A on patients with unexplained repeated implantation failure in IVF\/ICSI cycles: a retrospective cohort study","volume":"87","author":"Cheng","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib8","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.3390\/jcm10215040","article-title":"Special issue recurrent pregnancy loss: etiology, diagnosis, and therapy","volume":"10","author":"Christiansen","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.jri.2023.104157_bib9","article-title":"ESHRE good practice recommendations on recurrent implantation failure","volume":"2023","author":"Cimadomo","year":"2023","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.jri.2023.104157_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/164_2021_549","article-title":"A comprehensive review of calcineurin inhibitors used for immunosuppression in cardiac transplantation","volume":"272","author":"Engwenyu","year":"2022","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.jri.2023.104157_bib11","unstructured":"Food and Drug Administration. Highlights of prescribing information (tacrolimus). \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050709s031lbl.pdf\u3009, 2012 (accessed 24 July 2023)."},{"key":"10.1016\/j.jri.2023.104157_bib12","unstructured":"Food and Drug Administration. Prescribing Information (cyclosporine). \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/050715s035,050716s038lbl.pdf\u3009, 2020 (accessed 24 July 2023)."},{"key":"10.1016\/j.jri.2023.104157_bib13","first-page":"76","article-title":"Recurrent pregnancy loss: Etiology, diagnosis, and therapy","volume":"2","author":"Ford","year":"2009","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2023.104157_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.12891\/ceog2006.2015","article-title":"Analysis of the use of cyclosporin a to treat refractory immune recurrent spontaneous abortion","volume":"42","author":"Fu","year":"2015","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2023.104157_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2023.104157_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.clp.2020.08.003","article-title":"An update on biologic agents during pregnancy","volume":"47","author":"Hammad","year":"2020","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.jri.2023.104157_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/14647273.2021.1955415","article-title":"Changes in the T-helper 1 and 2 cell populations during pregnancy in tacrolimus-treated women with repeated implantation failure and recurrent pregnancy loss","volume":"25","author":"Hisano","year":"2022","journal-title":"Hum. Fertil. (Camb. )"},{"key":"10.1016\/j.jri.2023.104157_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ceca.2017.01.014","article-title":"Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion","volume":"63","author":"Hogan","year":"2017","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jri.2023.104157_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000515933","article-title":"Calcineurin inhibitor toxicity in solid organ transplantation","volume":"106","author":"Karolin","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.jri.2023.104157_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103105","article-title":"Recurrent miscarriages and the association with regulatory T cells; a systematic review","volume":"139","author":"Keller","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/aji.12483","article-title":"The uterine immune profile may help women with repeated unexplained embryo implantation failure after in vitro fertilization","volume":"75","author":"L\u00e9d\u00e9e","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01032","article-title":"Endometrial immune profiling: a method to design personalized care in assisted reproductive medicine","volume":"11","author":"L\u00e9d\u00e9e","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib23","first-page":"398","article-title":"Determination of clinical cellular immune markers in women with recurrent pregnancy loss","volume":"70","author":"Lee","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.12891\/ceog3375.2017","article-title":"Low dose cyclosporin a treatment increases live birth rate of unexplained recurrent abortion - initial cohort study","volume":"44","author":"Ling","year":"2017","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2023.104157_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00228-023-03473-9","article-title":"Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial","volume":"79","author":"Liu","year":"2023","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.jri.2023.104157_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-017-0315-9","article-title":"Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1\/Th2\/Treg paradigm in patients with unexplained recurrent miscarriage","volume":"15","author":"Liu","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jri.2023.104157_bib27","article-title":"Recurrent implantation failure: a comprehensive summary from etiology to treatment","volume":"13","author":"Ma","year":"2022","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.jri.2023.104157_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/1756-185X.14634","article-title":"Intravenous immunoglobulin for recurrent pregnancy losses? Possible mechanism and current evidence","volume":"26","author":"Ma","year":"2023","journal-title":"Int J. Rheum. Dis."},{"key":"10.1016\/j.jri.2023.104157_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1423-0410.1989.tb02018.x","article-title":"Prevention of recurrent spontaneous abortion by intravenous immunoglobulin","volume":"56","author":"Mueller-Eckhardt","year":"1989","journal-title":"Vox Sang."},{"key":"10.1016\/j.jri.2023.104157_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/aji.12338","article-title":"Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood Th1\/Th2 cell ratios","volume":"73","author":"Nakagawa","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jri.2023.104157_bib33","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jri.2023.104157_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00195","article-title":"The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases","volume":"11","author":"Park","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Saf."},{"key":"10.1016\/j.jri.2023.104157_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.fertnstert.2023.02.014","article-title":"Recurrent implantation failure: Reality or a statistical mirage?: consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure","volume":"120","author":"Pirtea","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2023.104157_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-021-00728-x","article-title":"Impacts of cyclosporin a on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: A retrospective cohort study","volume":"19","author":"Qu","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jri.2023.104157_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.17515","article-title":"Recurrent miscarriage green-top guideline no. 17","author":"Regan","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.jri.2023.104157_bib39","series-title":"Calcineurin inhibitors. Statpearls.","author":"Safarini","year":"2023"},{"key":"10.1016\/j.jri.2023.104157_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jog.15500","article-title":"Co-administration of tacrolimus and low molecular weight heparin in patients with a history of implantation failure and elevated peripheral blood natural killer cell proportion","volume":"49","author":"Shen","year":"2023","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.jri.2023.104157_bib41","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jri.2023.104157_bib42","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jri.2023.104157_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(81)90413-X","article-title":"Prevention of recurrent abortion with leucocyte transfusions","volume":"2","author":"Taylor","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2023.104157_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/a-1895-9940","article-title":"Recurrent miscarriage: diagnostic and therapeutic procedures. guideline of the DGGG, OEGGG AND SGGG (S2k-level, AWMF registry no.\u2009015\/050, may 2022)","volume":"83","author":"Toth","year":"2023","journal-title":"Geburtshilfe und Frauenheilkd."},{"key":"10.1016\/j.jri.2023.104157_bib45","article-title":"Th17\/Treg-cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A","volume":"21","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.jri.2023.104157_bib46","article-title":"T helper (th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/th2\/th9\/th17\/th22\/tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jri.2013.04.002","article-title":"Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage","volume":"99","author":"Wang","year":"2013","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib48","first-page":"247","article-title":"WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976","volume":"56","year":"1977","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jri.2023.104157_bib49","unstructured":"Wells G.A., et al., 2022. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. \u3008https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\u3009. (Accessed 24 July 2023)."},{"key":"10.1016\/j.jri.2023.104157_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0897.2010.00811.x","article-title":"Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood t cell activation","volume":"63","author":"Yang","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib51","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/dep343","article-title":"The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on art terminology, 2009\u2020","volume":"24","author":"Zegers-Hochschild","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2023.104157_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103366","article-title":"Mesenchymal stem cells enhance Treg immunosuppressive function at the fetal-maternal interface","volume":"148","author":"Zhang","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2023.104157_bib53","article-title":"Efficacy of intrauterine perfusion of cyclosporin a for intractable recurrent spontaneous abortion patients with endometrial alloimmune disorders: a randomized controlled trial","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Physiol."},{"key":"10.1016\/j.jri.2023.104157_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/FTD.0b013e3182708edf","article-title":"Pharmacokinetics of tacrolimus during pregnancy","volume":"34","author":"Zheng","year":"2012","journal-title":"Ther. Drug Monit."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037823003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037823003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:35:18Z","timestamp":1759034118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037823003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"alternative-id":["S0165037823003637"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2023.104157","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2023.104157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104157"}}